Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 8/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.36 |
| ▸ | REN | P00797 | 3/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | HTR6 | P50406 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4524658 | 1.00 | SLC6A3 (0.36) | SLC6A3SLC6A4RENTRPA1HTR6 | |
| SCHEMBL4516957 | 0.88 | SLC6A3 (0.36) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4514783 | 0.88 | SLC6A3 (0.36) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4514788 | 0.88 | SLC6A3 (0.36) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4520962 | 0.83 | SLC6A3 (0.43) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4528766 | 0.83 | SLC6A3 (0.43) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4520965 | 0.83 | SLC6A3 (0.43) | SLC6A3SLC6A4SLC6A2 | |
| SCHEMBL4509456 | 0.82 | SLC6A3 (0.44) | SLC6A3SLC6A4HTR6SIGMAR1SLC6A2 | |
| SCHEMBL4512323 | 0.82 | SLC6A3 (0.44) | SLC6A3SLC6A4HTR6SIGMAR1SLC6A2 | |
| SCHEMBL4509450 | 0.82 | SLC6A3 (0.44) | SLC6A3SLC6A4HTR6SIGMAR1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7476740-B2 | Monoamine transporter inhibitors; used for early diagnosis and treatment of neurological and psychiatric conditions | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2009-01-13 | — | — | US | disclosed |